Roger Ulrich
Login to view DISC.Roger Ulrich is a biotech entrepreneur and executive with over 30 years of experience in drug discovery and development. He founded Calistoga Pharmaceuticals, developing the cancer drug Zydelig®, and served as CSO at Acerta Pharma through its acquisition by AstraZeneca. He holds a PhD from West Virginia University.
Outside of his direct scientific and executive work, he shows an interest in broader public health discussions. He has shared positions from the American Society of Clinical Oncology on cancer risks associated with lifestyle choices, highlighting the importance of public awareness in disease prevention.
He founded Calistoga Pharmaceuticals and led the development of Zydelig®, which resulted in the companys acquisition by Gilead Sciences for up to $600 million.
Read the full overview →How Roger shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Roger cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.